Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...
TRENTON, N.J. — A less-expensive version of the world’s top-selling insulin, Sanofi’s Lantus, could go on sale in the U.S. late next year. The French drugmaker said Monday it settled a lawsuit over ...
Real World Outcome Study of Patients with Type 2 Diabetes Presented at American Diabetes Association 74th Scientific Sessions BRIDGEWATER, N.J., June 14, 2014 /PRNewswire/ -- Sanofi US announced today ...
Sanofi-Aventis US is rolling out a consumer campaign for its Lantus SoloStar pen aimed at getting people with type 2 diabetes to think differently about insulin. Dubbed “I Chose,” the effort is ...
∙ As a first result of the exclusive negotiations initiated in July, the two companies sign a global distribution agreement ∙ After an initial payment of €4 million, BIOCORP receives a new payment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback